Adjuvant Everolimus Falls Short in High-Risk Kidney Cancer
(MedPage Today) -- Adjuvant everolimus (Afinitor) failed to significantly improve recurrence-free survival (RFS) in patients with renal cell carcinoma (RCC) who were at high risk for recurrence after nephrectomy, according to results from a randomized... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 31, 2023 Category: Hematology Source Type: news
Adjuvant Everolimus Falls Short in High-Risk Renal Cancer
(MedPage Today) -- Adjuvant everolimus (Afinitor) failed to significantly improve recurrence-free survival (RFS) in patients with renal cell carcinoma (RCC) who were at high risk for recurrence after nephrectomy, according to results from a randomized... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 31, 2023 Category: Hematology Source Type: news
Upfront Systemic Therapy, Deferred Surgery Pass Muster in Advanced Kidney Cancer
(MedPage Today) -- CHICAGO -- Perioperative immunotherapy for advanced kidney cancer did not adversely affect outcomes with cytoreductive nephrectomy and appeared to have several beneficial effects, a small multicenter study showed.
Primary... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 2, 2023 Category: Hematology Source Type: news
Radiological Case: Renal Artery Pseudoaneurysm Radiological Case: Renal Artery Pseudoaneurysm
What was the cause of this patient ' s abdominal pain 4 weeks following laparoscopic partial nephrectomy?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 24, 2023 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news
How to Participate in Clinical Trials for Kidney Cancer
It is fortunate that, in a majority of cases, kidney cancer is caught before spreading to other parts of the body. For these patients, treatment usually involves a nephrectomy, which is the surgical removal of one or both of the kidneys. The goal of the surgery is to prevent the cancer from metastasizing. Unfortunately, many people who undergo a nephrectomy for high-risk disease—between 20% to 50%, according to recent estimates—will eventually go on to develop metastatic cancer.
Until recently, there wasn’t much a person’s care team could do in this situation to stop the cancer from coming back. Rel...
Source: TIME: Health - December 26, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Functional Adaptation After Nephrectomy and Increased ANP Functional Adaptation After Nephrectomy and Increased ANP
Are the elevated levels of atrial natriuretic peptide among patients who underwent nephrectomy associated with kidney functional adaptation after surgery?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 28, 2022 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancer
(MedPage Today) -- AUSTIN, Texas -- Cytoreductive nephrectomy improved overall survival (OS) by more than a year for patients with metastatic renal cell carcinoma (mRCC) with sarcomatoid or rhabdoid (S/R) dedifferentiation treated with immunotherapy... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 10, 2022 Category: Hematology Source Type: news
The Latest Breakthroughs That Could Improve Kidney Cancer Treatment
Dr. David McDermott started treating people with kidney cancer in the 1990s. Back then, he says the prognosis for most of his patients with advanced disease was dispiritingly grim. “We had very few treatment options, and the survival for patients was a year or less,” he recalls. “Radiation and chemotherapy were tried, but they didn’t work.”
Things began to change when researchers discovered that kidney cancers were highly “angiogenic” compared to most other forms of cancer, meaning that kidney tumors are rich in blood vessels. This insight supported the development of angiogenesis ...
Source: TIME: Health - November 1, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Coping With the Side Effects of Kidney-Cancer Treatment
Not long ago, the treatment options available to people with metastatic kidney cancer were few and feeble. Surgical removal of the affected tissue was an effective and often durable fix for people with cancer that was confined to the kidneys. But for the roughly 30% to 40% of people with kidney cancer that spreads to other parts of the body, the prognosis was dispiritingly grim.
Fortunately, things are much different today. “Since the early 2000s, we’ve had a class of drugs called blood-vessel inhibitors, and these made an immediate impact,” says Dr. Primo Lara, a professor, clinician, and director of the...
Source: TIME: Health - October 27, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Adjuvant Nivo+Ipi Fails in Kidney Cancer, in Contrast to Pembro Adjuvant Nivo+Ipi Fails in Kidney Cancer, in Contrast to Pembro
Six months of adjuvant nivolumab plus ipilimumab after nephrectomy for renal cell carcinoma offers no disease-free survival benefit, reveals trial that highlights treatment duration and tolerability.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Analysis Shows No Benefit for Cytoreductive Nephrectomy Analysis Shows No Benefit for Cytoreductive Nephrectomy
For patients with metastatic clear cell renal cell carcinoma, removing the kidney and its primary tumor is not associated with improved overall survival, a new analysis concludes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Fewer Complications With Robotic Nephrectomy in Complex Kidney Tumors
(MedPage Today) -- Robotic-assisted partial nephrectomy (RAPN) led to a lower rate of complications compared with open partial nephrectomy (OPN) in patients with intermediate- or high-complexity kidney tumors, the randomized OpeRa trial found... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - July 6, 2022 Category: Surgery Source Type: news
Rate of Major Complications Low With Living Donor Nephrectomy
FRIDAY, May 6, 2022 -- The overall complication rate for hand-assisted laparoscopic living donor nephrectomy (HALLDN) was 12.4 percent, and most complications occurred after discharge, according to a study published online April 27 in Mayo Clinic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 6, 2022 Category: Pharmaceuticals Source Type: news
Same-Day Discharge After Robot-Assisted Partial Nephrectomy May Be Feasible in Some Patients Same-Day Discharge After Robot-Assisted Partial Nephrectomy May Be Feasible in Some Patients
In selected patients undergoing robot-assisted partial nephrectomy (RAPN), same-day discharge is feasible, a small study suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 2, 2022 Category: Surgery Tags: Nephrology News Source Type: news
What Is Transperitoneal Nephrectomy?
Title: What Is Transperitoneal Nephrectomy?Category: Diseases and ConditionsCreated: 4/27/2022 12:00:00 AMLast Editorial Review: 4/27/2022 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - April 27, 2022 Category: Nutrition Source Type: news
